These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 27527709)
1. Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists. Liu S; Dakin LA; Xing L; Withka JM; Sahasrabudhe PV; Li W; Banker ME; Balbo P; Shanker S; Chrunyk BA; Guo Z; Chen JM; Young JA; Bai G; Starr JT; Wright SW; Bussenius J; Tan S; Gopalsamy A; Lefker BA; Vincent F; Jones LH; Xu H; Hoth LR; Geoghegan KF; Qiu X; Bunnage ME; Thorarensen A Sci Rep; 2016 Aug; 6():30859. PubMed ID: 27527709 [TBL] [Abstract][Full Text] [Related]
2. A Binding Site on IL-17A for Inhibitory Macrocycles Revealed by Hydrogen/Deuterium Exchange Mass Spectrometry. Espada A; Broughton H; Jones S; Chalmers MJ; Dodge JA J Med Chem; 2016 Mar; 59(5):2255-60. PubMed ID: 26854023 [TBL] [Abstract][Full Text] [Related]
3. Discovery of novel immunopharmacological ligands targeting the IL-17 inflammatory pathway. Álvarez-Coiradas E; Munteanu CR; Díaz-Sáez L; Pazos A; Huber KVM; Loza MI; Domínguez E Int Immunopharmacol; 2020 Dec; 89(Pt A):107026. PubMed ID: 33045560 [TBL] [Abstract][Full Text] [Related]
4. Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide. Liu S; Desharnais J; Sahasrabudhe PV; Jin P; Li W; Oates BD; Shanker S; Banker ME; Chrunyk BA; Song X; Feng X; Griffor M; Jimenez J; Chen G; Tumelty D; Bhat A; Bradshaw CW; Woodnutt G; Lappe RW; Thorarensen A; Qiu X; Withka JM; Wood LD Sci Rep; 2016 May; 6():26071. PubMed ID: 27184415 [TBL] [Abstract][Full Text] [Related]
6. Structural Insights into the Interleukin-17 Family Cytokines and Their Receptors. Liu S Adv Exp Med Biol; 2019; 1172():97-117. PubMed ID: 31628653 [TBL] [Abstract][Full Text] [Related]
7. Optimized methods for IL-17A refolding and anti-IL17A Fab production for co-crystallization with small molecules. Meng X; Zhang L; Wei H; Li F; Hu L; Ma H; Liu Q; Li X; Liu Z Biotechniques; 2020 Jul; 69(1):427-433. PubMed ID: 32336115 [TBL] [Abstract][Full Text] [Related]
8. A Michael Acceptor Analogue, SKSI-0412, Down-Regulates Inflammation and Proliferation Factors through Suppressing Signal Transducer and Activator of Transcription 3 Signaling in IL-17A-Induced Human Keratinocyte. Kim AR; Lee S; Shin JU; Seok SH; Suh YG; Kim DH Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445513 [TBL] [Abstract][Full Text] [Related]
9. The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties. Goepfert A; Lehmann S; Wirth E; Rondeau JM Sci Rep; 2017 Aug; 7(1):8906. PubMed ID: 28827714 [TBL] [Abstract][Full Text] [Related]
10. Molecular modeling and rational design of disulfide-stapled self-inhibitory peptides to target IL-17A/IL-17RA interaction. Huang W; Zhou Y; Pan C; Zhang X; Zhao H; Shen L J Mol Recognit; 2023 Aug; 36(8):e3045. PubMed ID: 37415317 [TBL] [Abstract][Full Text] [Related]
11. The flavonoid cyanidin blocks binding of the cytokine interleukin-17A to the IL-17RA subunit to alleviate inflammation in vivo. Liu C; Zhu L; Fukuda K; Ouyang S; Chen X; Wang C; Zhang CJ; Martin B; Gu C; Qin L; Rachakonda S; Aronica M; Qin J; Li X Sci Signal; 2017 Feb; 10(467):. PubMed ID: 28223414 [TBL] [Abstract][Full Text] [Related]
12. Crystal structures of interleukin 17A and its complex with IL-17 receptor A. Liu S; Song X; Chrunyk BA; Shanker S; Hoth LR; Marr ES; Griffor MC Nat Commun; 2013; 4():1888. PubMed ID: 23695682 [TBL] [Abstract][Full Text] [Related]
13. Antagonistic RNA aptamer specific to a heterodimeric form of human interleukin-17A/F. Adachi H; Ishiguro A; Hamada M; Sakota E; Asai K; Nakamura Y Biochimie; 2011 Jul; 93(7):1081-8. PubMed ID: 21524680 [TBL] [Abstract][Full Text] [Related]
14. Structure of IL-17A in complex with a potent, fully human neutralizing antibody. Gerhardt S; Abbott WM; Hargreaves D; Pauptit RA; Davies RA; Needham MR; Langham C; Barker W; Aziz A; Snow MJ; Dawson S; Welsh F; Wilkinson T; Vaugan T; Beste G; Bishop S; Popovic B; Rees G; Sleeman M; Tuske SJ; Coales SJ; Hamuro Y; Russell C J Mol Biol; 2009 Dec; 394(5):905-21. PubMed ID: 19835883 [TBL] [Abstract][Full Text] [Related]
15. Novel Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) from Natural Product Anabaenopeptin. Halland N; Brönstrup M; Czech J; Czechtizky W; Evers A; Follmann M; Kohlmann M; Schiell M; Kurz M; Schreuder HA; Kallus C J Med Chem; 2015 Jun; 58(11):4839-44. PubMed ID: 25990761 [TBL] [Abstract][Full Text] [Related]
16. Utilization of peptide phage display to investigate hotspots on IL-17A and what it means for drug discovery. Ting JP; Tung F; Antonysamy S; Wasserman S; Jones SB; Zhang FF; Espada A; Broughton H; Chalmers MJ; Woodman ME; Bina HA; Dodge JA; Benach J; Zhang A; Groshong C; Manglicmot D; Russell M; Afshar S PLoS One; 2018; 13(1):e0190850. PubMed ID: 29329326 [TBL] [Abstract][Full Text] [Related]
17. Advances in macrocyclic peptide-based antibiotics. Luther A; Bisang C; Obrecht D Bioorg Med Chem; 2018 Jun; 26(10):2850-2858. PubMed ID: 28886999 [TBL] [Abstract][Full Text] [Related]
18. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo. Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202 [TBL] [Abstract][Full Text] [Related]
19. Disulfide-rich macrocyclic peptides as templates in drug design. Northfield SE; Wang CK; Schroeder CI; Durek T; Kan MW; Swedberg JE; Craik DJ Eur J Med Chem; 2014 Apr; 77():248-57. PubMed ID: 24650712 [TBL] [Abstract][Full Text] [Related]
20. High Throughput Screening Assay to Identify Modulators of IL-17 Expression. Boudjelal M; Ruiz-Avendano AM; Colmenarejo G; Senar-Sancho SA; Barnes A; Harrison SA Comb Chem High Throughput Screen; 2017; 20(9):804-819. PubMed ID: 28571538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]